GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » Interest Coverage

Sopharma AD-Sofia (XBUL:SFA) Interest Coverage : 7.30 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Sopharma AD-Sofia's Operating Income for the three months ended in Dec. 2023 was лв19 Mil. Sopharma AD-Sofia's Interest Expense for the three months ended in Dec. 2023 was лв-3 Mil. Sopharma AD-Sofia's interest coverage for the quarter that ended in Dec. 2023 was 7.30. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Sopharma AD-Sofia's Interest Coverage or its related term are showing as below:

XBUL:SFA' s Interest Coverage Range Over the Past 10 Years
Min: 4.38   Med: 6.08   Max: 14.08
Current: 9.2


XBUL:SFA's Interest Coverage is ranked worse than
54.43% of 79 companies
in the Medical Distribution industry
Industry Median: 10.15 vs XBUL:SFA: 9.20

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Sopharma AD-Sofia Interest Coverage Historical Data

The historical data trend for Sopharma AD-Sofia's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Sopharma AD-Sofia Interest Coverage Chart

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.34 4.38 6.72 14.08 9.20

Sopharma AD-Sofia Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.21 17.55 12.66 3.59 7.30

Competitive Comparison of Sopharma AD-Sofia's Interest Coverage

For the Medical Distribution subindustry, Sopharma AD-Sofia's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia's Interest Coverage Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Interest Coverage falls into.



Sopharma AD-Sofia Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sopharma AD-Sofia's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Sopharma AD-Sofia's Interest Expense was лв-10 Mil. Its Operating Income was лв94 Mil. And its Long-Term Debt & Capital Lease Obligation was лв111 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2023 )/Interest Expense (A: Dec. 2023 )
=-1*93.991/-10.213
=9.20

Sopharma AD-Sofia's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the three months ended in Dec. 2023, Sopharma AD-Sofia's Interest Expense was лв-3 Mil. Its Operating Income was лв19 Mil. And its Long-Term Debt & Capital Lease Obligation was лв111 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2023 )/Interest Expense (Q: Dec. 2023 )
=-1*18.56/-2.542
=7.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Sopharma AD-Sofia  (XBUL:SFA) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Sopharma AD-Sofia Interest Coverage Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia (XBUL:SFA) Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (XBUL:SFA) Headlines

No Headlines